Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.
Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.
复制标题
DOI:
10.1158/1940-6207.capr-09-0083
复制
发表时间:
2009-06
期刊:
影响因子:
--
通讯作者:
Dong Z
中科院分区:
文献类型:
--
作者:
Bode AM;Dong Z
Epidemiologic studies indicate that green tea consumption decreases cancer risk (1–3). These data are supported by the results of numerous preclinical studies, which have shown that green and black tea are potent inhibitors of carcinogenesis in various rodent models (4–6), including models for cancers of the skin, lung, esophagus, stomach, liver, duodenum, small intestine, pancreas, colon-rectum, and mammary gland (1, 4, 6–11).Different tea preparations contain varying amounts of polyphenols, and epigallocatechin 3-gallate (EGCG) is the most abundant, best-studied, and possibly most potent (against cancer) polyphenol found in tea (4–6, 12–15). Besides EGCG, which may account for 50% to 80% of the total antioxidant polyphenols called catechins in tea (6, 12–16), other tea cate (−) chins include (−)-epigallocatechin,(−)-epicatechin gallate, and (−)-epicatechin. The achievable tissue concentrations of these polyphenols are in the low micromolar range, and therefore, anticarcinogenic effects observed with much higher concentrations in vitro may not be relevant to the in vivo anticarcinogenic process (4, 5, 17).